Abivax S.A.
AAVXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -49.7% | -41% | 202.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 83.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,640.3% | -2,298% | -1,176.3% | -4,011% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,996.7% | -2,361.6% | -1,203% | -4,266.7% |
| EPS Diluted | -1.59 | -1.5 | -1.3 | -1.91 |
| % Growth | -6% | -15.4% | 31.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |